ArticleCancer medicine2026

A Real-World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First-Line Lenvatinib.

Shou-Wu Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.